170 related articles for article (PubMed ID: 28526986)
1. Implementation of Quality by Design for Formulation of Rebamipide Gastro-retentive Tablet.
Ha JM; Seo JW; Kim SH; Kim JY; Park CW; Rhee YS; Park ES
AAPS PharmSciTech; 2017 Nov; 18(8):3129-3139. PubMed ID: 28526986
[TBL] [Abstract][Full Text] [Related]
2. Development of sustained release gastro-retentive tablet formulation of nicardipine hydrochloride using quality by design (QbD) approach.
Chudiwal VS; Shahi S; Chudiwal S
Drug Dev Ind Pharm; 2018 May; 44(5):787-799. PubMed ID: 29198152
[TBL] [Abstract][Full Text] [Related]
3. An integrated, quality by design (QbD) approach for design, development and optimization of orally disintegrating tablet formulation of carbamazepine.
Mishra SM; Rohera BD
Pharm Dev Technol; 2017 Nov; 22(7):889-903. PubMed ID: 27346282
[TBL] [Abstract][Full Text] [Related]
4. Development and in vitro evaluation of pH-independent release matrix tablet of weakly acidic drug valsartan using quality by design tools.
Saydam M; Takka S
Drug Dev Ind Pharm; 2018 Dec; 44(12):1905-1917. PubMed ID: 29969042
[TBL] [Abstract][Full Text] [Related]
5. Design and evaluation of in vivo bioavailability in beagle dogs of bilayer tablet consisting of immediate release nanosuspension and sustained release layers of rebamipide.
Jin G; Ngo HV; Wang J; Cui JH; Cao QR; Park C; Jung M; Lee BJ
Int J Pharm; 2022 May; 619():121718. PubMed ID: 35381311
[TBL] [Abstract][Full Text] [Related]
6. Quality-by-design approach for the development of telmisartan potassium tablets.
Oh GH; Park JH; Shin HW; Kim JE; Park YJ
Drug Dev Ind Pharm; 2018 May; 44(5):837-848. PubMed ID: 29252038
[TBL] [Abstract][Full Text] [Related]
7. Original research paper. Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach.
Gavan A; Porfire A; Marina C; Tomuta I
Acta Pharm; 2017 Mar; 67(1):53-70. PubMed ID: 28231048
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of floating tablet of H2-receptor antagonist.
Kesarla RS; Vora PA; Sridhar BK; Patel G; Omri A
Drug Dev Ind Pharm; 2015; 41(9):1499-511. PubMed ID: 25243639
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers.
Cho HY; Yoon H; Park GK; Lee YB
Clin Ther; 2009 Nov; 31(11):2712-21. PubMed ID: 20110013
[TBL] [Abstract][Full Text] [Related]
10. Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation.
Qin C; Wu M; Xu S; Wang X; Shi W; Dong Y; Yang L; He W; Han X; Yin L
Int J Pharm; 2018 Jul; 545(1-2):37-44. PubMed ID: 29649518
[TBL] [Abstract][Full Text] [Related]
11. QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride.
Bansal S; Beg S; Asthana A; Garg B; Asthana GS; Kapil R; Singh B
Drug Deliv; 2016; 23(2):437-51. PubMed ID: 24865292
[TBL] [Abstract][Full Text] [Related]
12. Formulation of solid dispersion of rebamipide evaluated in a rat model for improved bioavailability and efficacy.
Tung NT; Park CW; Oh TO; Kim JY; Ha JM; Rhee YS; Park ES
J Pharm Pharmacol; 2011 Dec; 63(12):1539-47. PubMed ID: 22060284
[TBL] [Abstract][Full Text] [Related]
13. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide.
Gao Y; Gao Y; Yin F; Wang M; Wang Z; Ye T; Yang Y; Pan WS; Yang X
Drug Dev Ind Pharm; 2015; 41(9):1443-51. PubMed ID: 25190152
[TBL] [Abstract][Full Text] [Related]
14. Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets.
Badawy SI; Narang AS; LaMarche KR; Subramanian GA; Varia SA; Lin J; Stevens T; Shah PA
J Pharm Sci; 2016 Jan; 105(1):168-81. PubMed ID: 26852852
[TBL] [Abstract][Full Text] [Related]
15. QbD-Oriented Development and Characterization of Effervescent Floating-Bioadhesive Tablets of Cefuroxime Axetil.
Bansal S; Beg S; Garg B; Asthana A; Asthana GS; Singh B
AAPS PharmSciTech; 2016 Oct; 17(5):1086-99. PubMed ID: 26527606
[TBL] [Abstract][Full Text] [Related]
16. Implementation of Quality by Design (QbD) for development of bilayer tablets.
Simão J; Chaudhary SA; Ribeiro AJ
Eur J Pharm Sci; 2023 May; 184():106412. PubMed ID: 36828037
[TBL] [Abstract][Full Text] [Related]
17. Risk-based approach for systematic development of gastroretentive drug delivery system.
Mirani AG; Patankar SP; Kadam VJ
Drug Deliv Transl Res; 2016 Oct; 6(5):579-96. PubMed ID: 27468861
[TBL] [Abstract][Full Text] [Related]
18. QbD-Enabled Development of Novel Stimuli-Responsive Gastroretentive Systems of Acyclovir for Improved Patient Compliance and Biopharmaceutical Performance.
Singh B; Kaur A; Dhiman S; Garg B; Khurana RK; Beg S
AAPS PharmSciTech; 2016 Apr; 17(2):454-65. PubMed ID: 26238805
[TBL] [Abstract][Full Text] [Related]
19. Development of a rebamipide solid dispersion system with improved dissolution and oral bioavailability.
Pradhan R; Tran TH; Choi JY; Choi IS; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2015 Apr; 38(4):522-33. PubMed ID: 24895145
[TBL] [Abstract][Full Text] [Related]
20. Effect of Formulation Parameters on Enalapril Maleate Mucoadhesive Buccal Tablet Using Quality by Design (QbD) Approach.
Singh S; Chaurasia A; Gupta N; Rajput DS
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2024 Jun; 40():e20240003. PubMed ID: 38925868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
